Cyber Swan Sale

50% Off Elite

Days

Hours

Mins

Sec

Get our most powerful screeners, new charting tools, and the fastest ad-free experience at our best price ever. One last chance.

Peers: ALGN SYK JNJ ISRG BSX ZBH MDT BAX HOLX STE

| Held by: VTI VOO VB VBR IVV SPY RSP XLV IWR VHT

Index	S&P 500	P/E	37.46	EPS (ttm)	2.03	Insider Own	0.65%	Shs Outstand	198.80M	Perf Week	0.11%
Market Cap	15.13B	Forward P/E	17.29	EPS next Y	4.40	Insider Trans	1.41%	Shs Float	197.52M	Perf Month	8.85%
Enterprise Value	17.48B	PEG	4.05	EPS next Q	1.11	Inst Own	104.22%	Short Float	3.50%	Perf Quarter	13.34%
Income	407.80M	P/S	3.74	EPS this Y	10.97%	Inst Trans	1.85%	Short Ratio	2.57	Perf Half Y	13.73%
Sales	4.05B	P/B	1.81	EPS next Y	7.50%	ROA	3.33%	Short Interest	6.91M	Perf YTD	-17.23%
Book/sh	42.02	P/C	121.12	EPS next 5Y	9.25%	ROE	5.01%	52W High	106.63 -28.64%	Perf Year	-26.43%
Cash/sh	0.63	P/FCF	36.73	EPS past 3/5Y	-49.03% -3.45%	ROIC	3.78%	52W Low	61.78 23.18%	Perf 3Y	-3.18%
Dividend Est.	-	EV/EBITDA	15.74	Sales past 3/5Y	10.05% 7.98%	Gross Margin	62.03%	Volatility	2.00% 2.47%	Perf 5Y	-6.48%
Dividend TTM	-	EV/Sales	4.32	EPS Y/Y TTM	12.94%	Oper. Margin	18.31%	ATR (14)	1.92	Perf 10Y	112.61%
Dividend Ex-Date	Jul 26, 2023	Quick Ratio	1.24	Sales Y/Y TTM	6.35%	Profit Margin	10.08%	RSI (14)	60.53	Recom	2.10
Dividend Gr. 3/5Y	- -	Current Ratio	2.12	EPS Q/Q	-5.82%	SMA20	4.11%	Beta	1.03	Target Price	81.88
Payout	0.00%	Debt/Eq	0.30	Sales Q/Q	5.73%	SMA50	6.49%	Rel Volume	1.08	Prev Close	77.41
Employees	16000	LT Debt/Eq	0.29	Earnings	Dec 04 AMC	SMA200	1.43%	Avg Volume	2.68M	Price	76.09
IPO	Jan 21, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.23% -0.34%	Trades		Volume	2,491,754	Change	-1.70%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-13-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$72
Oct-13-25	Initiated	Barclays	Overweight	$85
Oct-01-25	Initiated	Goldman	Sell	$64
Aug-28-25	Downgrade	Citigroup	Buy → Neutral	$72
Jul-22-25	Upgrade	BNP Paribas Exane	Neutral → Outperform	$92
Jun-17-25	Upgrade	Needham	Hold → Buy	$94
May-30-25	Downgrade	JP Morgan	Overweight → Neutral	$76
Aug-29-24	Reiterated	Piper Sandler	Overweight	$115 → $120
Jul-16-24	Upgrade	Jefferies	Hold → Buy	$107 → $115
Mar-19-24	Upgrade	Redburn Atlantic	Neutral → Buy	$125
Mar-13-24	Upgrade	JP Morgan	Neutral → Overweight	$100 → $120
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-30-23	Initiated	BofA Securities	Buy	$380
Oct-05-23	Downgrade	Redburn Atlantic	Overweight → Neutral	$390 → $343
May-30-23	Initiated	Morgan Stanley	Equal-Weight	$410
Dec-22-22	Initiated	Mizuho	Buy	$375
Nov-30-22	Upgrade	Robert W. Baird	Neutral → Outperform	$345 → $375
Oct-12-22	Downgrade	Jefferies	Buy → Hold	$400 → $295
Aug-29-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-17-22	Upgrade	Citigroup	Neutral → Buy	$460 → $405

Show Previous Ratings

Dec-01-25 09:15AM	Curious about The Cooper Companies (COO) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
06:11AM	1 Profitable Stock to Own for Decades and 2 We Find Risky (StockStory)
Nov-30-25 07:27AM	Stocks drift back towards record highs as the final month of 2025 gets underway: What to watch this week (Yahoo Finance)
07:27AM	Stocks drift back toward record highs as the final month of 2025 gets underway: What to watch this week (Yahoo Finance)
Nov-27-25 10:00AM	The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy? (Zacks)
11:36PM	Loading…
Nov-23-25 11:36PM	1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds (StockStory)
Nov-21-25 06:36PM	CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know (StockStory) +6.13%
Nov-19-25 06:38AM	Cooper Companies Stock: Analyst Estimates & Ratings (Barchart)
Nov-14-25 05:10PM	Jana Partners' Strategic Move: Significant Addition of The Cooper Companies Inc (GuruFocus.com)
Nov-13-25 05:20PM	Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
09:45AM	Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls (The Fly)
09:10AM	Here Are Thursdays Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More (24/7 Wall St.)
Nov-06-25 07:40AM	Becton Dickinson (BDX) Tops Q4 Earnings and Revenue Estimates (Zacks)
Nov-05-25 06:30PM	Conmed (CNMD) Tops Q3 Earnings and Revenue Estimates (Zacks)
Nov-04-25 04:15PM	CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025 (GlobeNewswire)
12:00PM	Loading…
Nov-03-25 12:00PM	Can Sustained Product Demand Drive BDX Stock Before Q4 Earnings? (Zacks)
Oct-31-25 10:23AM	4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks (Zacks)
Oct-28-25 01:54AM	What to Expect From Cooper Companies Next Quarterly Earnings Report (Barchart)
Oct-21-25 09:24AM	Company News for Oct 21, 2025 (Zacks)
Oct-20-25 09:34AM	Stocks to Watch Monday: Amazon, Zions Bancorp, Kering (The Wall Street Journal)
08:21AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:41AM	Cooper Cos. Stock Rises as Report Says Activist Investor Takes Stake (Barrons.com)
07:25AM	Activist Jana Pushes Big Contact-Lens Combination of Cooper and Bausch + Lomb (The Wall Street Journal)
Oct-19-25 08:00PM	Activist Jana Takes Stake in Cooper, a Maker of Medical Devices (The Wall Street Journal)
Oct-16-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Oct-01-25 11:01AM	Goldman Sachs initiates ophthalmology coverage: Buy Glaukos, sell Cooper (Investing.com)
Sep-26-25 11:30AM	The Cooper Companies (COO) Up 3.6% Since Last Earnings Report: Can It Continue? (Zacks)
12:39AM	3 Healthcare Stocks That Fall Short (StockStory)
Sep-22-25 09:46AM	Reasons to Retain Cooper Companies Stock in Your Portfolio for Now (Zacks)
Sep-19-25 01:55AM	Is Cooper Companies Stock Underperforming the S&P 500? (Barchart)
11:42AM	Loading…
Sep-18-25 11:42AM	Why CooperCompanies (COO) Stock Is Up Today (StockStory)
Sep-17-25 04:15PM	CooperCompanies Announces Expanded Share Repurchase Program (GlobeNewswire)
Sep-15-25 09:40AM	Here's Why The Cooper Companies (COO) is a Strong Value Stock (Zacks)
Sep-09-25 12:02AM	3 Reasons COO is Risky and 1 Stock to Buy Instead (StockStory)
Sep-03-25 01:31AM	5 Insightful Analyst Questions From CooperCompanies's Q2 Earnings Call (StockStory)
Sep-02-25 03:30PM	Why CooperCompanies (COO) Shares Are Falling Today (StockStory)
Sep-01-25 09:15AM	Interpreting The Cooper Companies (COO) International Revenue Trends (Zacks)
Aug-31-25 11:34PM	Medical Devices & Supplies - Diversified Stocks Q2 Recap: Benchmarking CooperCompanies (NASDAQ:COO) (StockStory)
Aug-29-25 09:47AM	COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down (Zacks)
09:40AM	Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term (Zacks)
Aug-28-25 05:28PM	Why Cooper Companies Stock Sank by 13% Today (Motley Fool) -12.85%
04:25PM	These Stocks Moved the Most Today: Nvidia, Snowflake, Pure Storage, CrowdStrike, Hormel Foods, Cooper, HP, and More (Barrons.com)
04:05PM	Why CooperCompanies (COO) Shares Are Falling Today (StockStory)
11:48AM	Cooper Cos. Is Falling on Earnings. Why Citi Downgraded the Stock. (Barrons.com)
11:30AM	Top Stock Movers Now: Hormel, Best Buy, Snowflake, and More (Investopedia)
11:20AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
11:12AM	These Stocks Are Moving the Most Today: Nvidia, Snowflake, Pure Storage, CrowdStrike, Hormel Foods, Cooper, HP, and More (Barrons.com)
09:50AM	COO Q2 Deep Dive: Margin Pressures and Product Shifts Drive Cautious Outlook (StockStory)
09:39AM	Five Below upgraded, Bill downgraded: Wall Street's top analyst calls (The Fly)
05:46AM	Snowflake shares jump after earnings, and other early market movers (MarketWatch)
05:10AM	These Stocks Are Moving the Most Today: Nvidia, CrowdStrike, Snowflake, Cooper, HP, and More (Barrons.com)
03:06AM	The Cooper Companies Inc (COO) Q3 2025 Earnings Call Highlights: Strong Non-GAAP Earnings ... (GuruFocus.com)
Aug-27-25 06:00PM	Here's What Key Metrics Tell Us About The Cooper Companies (COO) Q3 Earnings (Zacks)
05:25PM	The Cooper Companies (COO) Q3 Earnings Beat Estimates (Zacks)
04:49PM	CooperCompanies's (NASDAQ:COO) Q2 Earnings Results: Revenue In Line With Expectations But Stock Drops 11% (StockStory)
04:15PM	CooperCompanies Announces Third Quarter 2025 Results (GlobeNewswire)
Aug-26-25 06:42PM	Analysts Love These 3 Companies Reporting Earnings This Week (MarketBeat)
11:40AM	COO vs. MMSI: Which Stock Is the Better Value Option? (Zacks)
09:55AM	How Much Upside is Left in The Cooper Companies (COO)? Wall Street Analysts Think 26.47% (Zacks)
08:22AM	Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand (Zacks)
Aug-25-25 11:02PM	CooperCompanies (COO) Q2 Earnings Report Preview: What To Look For (StockStory)
09:51AM	Do Wall Street Analysts Like Cooper Companies Stock? (Barchart)
Aug-22-25 09:15AM	The Cooper Companies (COO) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Aug-20-25 10:00AM	The Cooper Companies (COO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Aug-19-25 08:50AM	Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds (Zacks)
Aug-14-25 05:30PM	Plus Therapeutics (PSTV) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:15PM	CooperCompanies to Participate in the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-12-25 10:58AM	Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies (Zacks)
08:13AM	The Cooper Companies (COO) Traded Down in Q2 Despite Strong Results (Insider Monkey)
Aug-11-25 08:28AM	4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks (Zacks)
Aug-07-25 07:40AM	Becton Dickinson (BDX) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Aug-06-25 05:25PM	McKesson (MCK) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
Aug-05-25 12:16PM	Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings? (Zacks)
12:00PM	All You Need to Know About The Cooper Companies (COO) Rating Upgrade to Buy (Zacks)
11:40AM	COO or SAUHY: Which Is the Better Value Stock Right Now? (Zacks)
07:36AM	Will GLP-1 Demand Drive MCK's Top Line This Earnings Season? (Zacks)
12:00AM	CooperCompanies (COO): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jul-31-25 08:50AM	Should You Continue to Hold The Cooper Companies (COO)? (Insider Monkey)
Jul-25-25 07:55AM	What to Expect From Cooper Companies' Q3 2025 Earnings Report (Barchart)
Jul-24-25 04:15PM	CooperCompanies Announces Release Date for Third Quarter 2025 (GlobeNewswire)
Jul-22-25 11:56AM	CooperCompanies (COO) Stock Trades Up, Here Is Why (StockStory)
Jul-14-25 06:20AM	Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar? (Zacks)
Jul-02-25 08:21AM	COO Stock Declines Despite Strong Core Growth Amid Fertility Woes (Zacks)
Jul-01-25 01:32AM	The 5 Most Interesting Analyst Questions From CooperCompanies's Q1 Earnings Call (StockStory)
Jun-23-25 11:31PM	Medical Devices & Supplies - Diversified Stocks Q1 Teardown: CooperCompanies (NASDAQ:COO) Vs The Rest (StockStory)
09:32AM	HOLX vs. COO: Which GYN Surgical Stock Is the Better Investment Now? (Zacks)
Jun-19-25 11:20AM	How is Cooper Companies Stock Performance Compared to Other Medical Instruments & Supplies Stocks? (Barchart)
Jun-18-25 09:51AM	Roku upgraded, Sarepta downgraded: Wall Streets top analyst calls (TipRanks)
Jun-07-25 09:47AM	3 Oversold Stocks Flashing Bullish Reversal Signals (MarketBeat)
Jun-05-25 05:37PM	S&P 500 Gains and Losses Today: Tesla Shares Skid as Trump and Musk Tussle Over Budget Bill (Investopedia) +5.58%
Jun-03-25 09:45AM	Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term (Zacks)
Jun-02-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:15AM	Understanding The Cooper Companies (COO) Reliance on International Revenue (Zacks)
08:43AM	COO Q2 Earnings Signal Growth and Caution: How to Play the Stock? (Zacks)
May-30-25 08:47PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research) -14.61%
02:13PM	Cooper Stock Sinks as Contact Lens Maker Cuts Full-Year Organic Growth Forecast (Investopedia)
12:41PM	Why CooperCompanies (COO) Stock Is Falling Today (StockStory)
11:59AM	Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More (Investopedia)
11:40AM	XRAY vs. COO: Which Stock Should Value Investors Buy Now? (Zacks)
09:32AM	COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down (Zacks)

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kurzius Lawrence Erik	Director	Sep 29 '25	Buy	68.39	2,000	136,780	5,777	Sep 29 08:36 PM
White Albert G III	President & CEO	Sep 05 '25	Buy	68.39	10,000	683,900	226,151	Sep 05 05:10 PM
Warner Gerard H III	President, CooperVision, Inc.	Sep 05 '25	Buy	69.23	1,450	100,384	18,319	Sep 05 04:07 PM
McBride Daniel G	EVP & Chief Operating Officer	Sep 02 '25	Buy	65.04	3,000	195,120	63,120	Sep 02 05:17 PM
Andrews Brian G	EVP, CFO & Treasurer	Sep 02 '25	Buy	65.68	1,525	100,162	22,191	Sep 02 05:16 PM
KOZY WILLIAM A	Director	Apr 01 '25	Option Exercise	0.00	2,857	0	31,149	Apr 03 04:09 PM
WEISS ROBERT S	Director	Apr 01 '25	Option Exercise	0.00	2,993	0	288,945	Apr 03 04:09 PM
Rivas Maria	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	2,721	Apr 03 04:08 PM
MADDEN TERESA S	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	12,357	Apr 03 04:08 PM
Lucchese Cynthia L	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	7,661	Apr 03 04:07 PM
Kurzius Lawrence Erik	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	3,777	Apr 03 04:07 PM
Jay Colleen	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	29,521	Apr 03 04:06 PM
Ricupati Agostino	SVP & CAO	Apr 01 '25	Option Exercise	0.00	2,076	0	9,044	Apr 03 04:06 PM
McBride Daniel G	EVP & Chief Operating Officer	Feb 01 '25	Option Exercise	0.00	22,777	0	71,687	Feb 04 04:25 PM
White Albert G III	President & CEO	Feb 01 '25	Option Exercise	0.00	84,264	0	258,941	Feb 04 04:25 PM
Andrews Brian G	EVP, CFO & Treasurer	Feb 01 '25	Option Exercise	0.00	16,850	0	23,464	Feb 04 04:24 PM
Sheffield Holly R	President, CSI	Feb 01 '25	Option Exercise	0.00	17,309	0	45,843	Feb 04 04:24 PM
White Albert G III	President & CEO	Jan 08 '25	Option Exercise	0.00	18,340	0	183,613	Jan 10 04:12 PM
Warner Gerard H III	President, CooperVision, Inc.	Jan 08 '25	Option Exercise	0.00	13,328	0	23,763	Jan 10 04:12 PM
Sheffield Holly R	President, CSI	Jan 08 '25	Option Exercise	0.00	4,900	0	30,898	Jan 10 04:11 PM
Ricupati Agostino	SVP & CAO	Jan 08 '25	Option Exercise	0.00	4,472	0	9,328	Jan 10 04:11 PM
McBride Daniel G	EVP & Chief Operating Officer	Jan 08 '25	Option Exercise	0.00	8,728	0	53,424	Jan 10 04:11 PM
Andrews Brian G	EVP, CFO & Treasurer	Jan 08 '25	Option Exercise	0.00	6,420	0	13,034	Jan 10 04:10 PM
Khadder Nicholas	VP, General Counsel & Corp Sec	Jan 08 '25	Option Exercise	0.00	3,492	0	4,369	Jan 10 04:10 PM

Open in Screener

OMCL

Omnicell, Inc

Dec 02 • 03:01PM ET

37.63

+1.51 4.17 %

Healthcare • Health Information Services • USA • NASD

Peers: MDB INSP HSIC MCK PDCO GEHC ADUS EHTH AMWL HSTM

| Held by: IJR VTI IWM VB VBR BOTZ VXF IJS SPSM IWN

Index	RUT	P/E	88.24	EPS (ttm)	0.43	Insider Own	2.98%	Shs Outstand	44.88M	Perf Week	3.83%
Market Cap	1.69B	Forward P/E	20.48	EPS next Y	1.84	Insider Trans	-0.55%	Shs Float	43.54M	Perf Month	12.09%
Enterprise Value	1.67B	PEG	12.15	EPS next Q	0.49	Inst Own	101.52%	Short Float	5.01%	Perf Quarter	14.65%
Income	19.92M	P/S	1.43	EPS this Y	0.00%	Inst Trans	-3.60%	Short Ratio	5.11	Perf Half Y	21.30%
Sales	1.18B	P/B	1.38	EPS next Y	7.46%	ROA	0.94%	Short Interest	2.18M	Perf YTD	-15.48%
Book/sh	27.21	P/C	7.49	EPS next 5Y	7.26%	ROE	1.62%	52W High	47.84 -21.35%	Perf Year	-22.35%
Cash/sh	5.02	P/FCF	15.15	EPS past 3/5Y	-44.95% -28.29%	ROIC	1.41%	52W Low	22.66 66.05%	Perf 3Y	-27.71%
Dividend Est.	-	EV/EBITDA	15.82	Sales past 3/5Y	-0.59% 4.39%	Gross Margin	43.82%	Volatility	3.66% 3.88%	Perf 5Y	-65.08%
Dividend TTM	-	EV/Sales	1.42	EPS Y/Y TTM	210.53%	Oper. Margin	1.57%	ATR (14)	1.35	Perf 10Y	30.83%
Dividend Ex-Date	-	Quick Ratio	1.17	Sales Y/Y TTM	10.67%	Profit Margin	1.69%	RSI (14)	66.71	Recom	1.75
Dividend Gr. 3/5Y	- -	Current Ratio	1.41	EPS Q/Q	-35.99%	SMA20	4.99%	Beta	0.80	Target Price	47.33
Payout	0.00%	Debt/Eq	0.17	Sales Q/Q	9.99%	SMA50	14.85%	Rel Volume	0.59	Prev Close	36.12
Employees	3670	LT Debt/Eq	0.16	Earnings	Oct 30 BMO	SMA200	18.19%	Avg Volume	426.99K	Price	37.63
IPO	Aug 07, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	40.69% 5.09%	Trades		Volume	216,934	Change	4.17%

Date	Action	Analyst	Rating Change	Price Target Change
May-14-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$35
Oct-31-24	Downgrade	BofA Securities	Buy → Neutral	$44 → $57
Aug-02-24	Upgrade	Barclays	Underweight → Equal Weight	$26 → $39
Jan-03-24	Initiated	Barclays	Underweight	$33
Nov-03-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$39 → $28
Nov-03-23	Upgrade	Piper Sandler	Neutral → Overweight	$70 → $39
Nov-03-23	Downgrade	BTIG Research	Buy → Neutral
Oct-11-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Sep-26-23	Reiterated	Wells Fargo	Underweight	$56 → $39
Aug-02-23	Downgrade	Piper Sandler	Overweight → Neutral	$66 → $70
Jul-20-23	Downgrade	Wells Fargo	Overweight → Underweight	$65 → $56
Feb-27-23	Upgrade	The Benchmark Company	Hold → Buy	$68
Nov-03-22	Downgrade	The Benchmark Company	Buy → Hold
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$130
Sep-09-22	Initiated	BofA Securities	Buy	$120
Jul-15-22	Initiated	SVB Leerink	Mkt Perform	$124
Dec-06-21	Resumed	Wells Fargo	Overweight	$203
Jun-09-21	Initiated	JP Morgan	Neutral	$146
May-24-21	Initiated	BTIG Research	Buy	$165
Feb-02-21	Upgrade	Piper Sandler	Neutral → Overweight	$86 → $147

Show Previous Ratings

Nov-27-25 09:55AM	Wall Street Analysts Think Omnicell (OMCL) Could Surge 30.93%: Read This Before Placing a Bet (Zacks)
Nov-20-25 04:01PM	Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference (Business Wire)
11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Nov-10-25 09:55AM	Wall Street Analysts Believe Omnicell (OMCL) Could Rally 34.53%: Here's is How to Trade (Zacks)
Nov-04-25 11:40AM	OMCL vs. HIMS: Which Stock Is the Better Value Option? (Zacks)
09:21AM	Loading…
09:21AM	Buy 5 Stocks With Extensive Robotics Application for the Rest of 2025 (Zacks)
Nov-03-25 12:20PM	Earnings Estimates Moving Higher for Omnicell (OMCL): Time to Buy? (Zacks)
11:40AM	OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? (Zacks)
Oct-30-25 06:45PM	Why Omnicell Stock Crushed the Market Today (Motley Fool) +13.56%
04:31PM	Omnicell Inc (OMCL) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
02:35PM	Why Omnicell (OMCL) Stock Is Trading Up Today (StockStory)
07:45AM	Omnicell (OMCL) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:54AM	Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars (StockStory)
06:40AM	Omnicell: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Omnicell Announces Third Quarter 2025 Financial Results (Business Wire)
11:15PM	Loading…
Oct-28-25 11:15PM	Omnicell (OMCL) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Oct-27-25 10:00AM	Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-24-25 09:55AM	Wall Street Analysts See a 43.74% Upside in Omnicell (OMCL): Can the Stock Really Move This High? (Zacks)
Oct-23-25 10:00AM	Earnings Preview: Omnicell (OMCL) Q3 Earnings Expected to Decline (Zacks)
09:40AM	Are Investors Undervaluing Omnicell (OMCL) Right Now? (Zacks)
Oct-21-25 10:46PM	Omnicell, Inc. (OMCL): A Bull Case Theory (Insider Monkey)
05:19AM	10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? (Zacks)
Oct-17-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Oct-14-25 03:00PM	NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings (Zacks)
Oct-07-25 09:40AM	Is Omnicell (OMCL) Stock Undervalued Right Now? (Zacks)
08:23AM	Reasons to Add Omnicell Stock to Your Portfolio Right Now (Zacks)
Oct-06-25 04:01PM	Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025 (Business Wire)
Oct-02-25 12:43AM	1 Stock Under $50 with Promising Prospects and 2 Facing Challenges (StockStory)
Oct-01-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
09:30AM	BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience (Zacks)
10:05AM	Loading…
Sep-30-25 10:05AM	OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? (Zacks)
Sep-18-25 09:40AM	Is Omnicell (OMCL) a Great Value Stock Right Now? (Zacks)
Sep-15-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Sep-12-25 03:35AM	The Zacks Analyst Blog Highlights Butterfly Network, Omnicell, NVIDIA, Palantir and IBM (Zacks)
Sep-11-25 03:00PM	NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy (Zacks)
09:55AM	Wall Street Analysts Think Omnicell (OMCL) Could Surge 39.36%: Read This Before Placing a Bet (Zacks)
Sep-05-25 12:34AM	3 Low-Volatility Stocks We Steer Clear Of (StockStory)
Sep-03-25 11:30AM	Why Is Inspire (INSP) Up 7.5% Since Last Earnings Report? (Zacks)
Sep-01-25 12:02AM	Omnicell (OMCL): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Aug-27-25 11:38PM	Q2 Earnings Highlights: Omnicell (NASDAQ:OMCL) Vs The Rest Of The Healthcare Technology for Providers Stocks (StockStory)
Aug-26-25 12:20PM	Earnings Estimates Rising for Omnicell (OMCL): Will It Gain? (Zacks)
09:55AM	Wall Street Analysts Believe Omnicell (OMCL) Could Rally 34.18%: Here's is How to Trade (Zacks)
Aug-25-25 04:05PM	Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer (Business Wire)
Aug-14-25 09:34AM	Pharmacy Automation Company Evaluation Report 2025 \| BD, Omnicell, and Capsa Healthcare Lead in Medical Technology, Pharmacy Automation, and Medication Management Solutions (GlobeNewswire)
Aug-13-25 12:04AM	OMCL Q2 Deep Dive: Product Innovation and Recurring Revenue Drive Upbeat Guidance (StockStory)
Aug-12-25 11:50PM	5 Must-Read Analyst Questions From Omnicell's Q2 Earnings Call (StockStory)
Aug-01-25 09:55AM	Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High? (Zacks)
Jul-31-25 07:45AM	Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:59AM	Omnicell (NASDAQ:OMCL) Reports Upbeat Q2, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
06:43AM	Omnicell: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	Omnicell Announces Second Quarter 2025 Results (Business Wire)
Jul-30-25 01:09PM	Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings? (Zacks)
11:40AM	OMCL vs. DOCS: Which Stock Is the Better Value Option? (Zacks)
Jul-29-25 11:04PM	Earnings To Watch: Omnicell (OMCL) Reports Q2 Results Tomorrow (StockStory)
Jul-28-25 10:00AM	Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jul-24-25 10:00AM	Analysts Estimate Omnicell (OMCL) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:00AM	American Well (AMWL) Soars 5.0%: Is Further Upside Left in the Stock? (Zacks)
12:33AM	3 Healthcare Stocks We Approach with Caution (StockStory)
Jul-21-25 12:20PM	Why Omnicell (OMCL) Stock Is Trading Up Today (StockStory)
Jul-18-25 08:34AM	Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? (Zacks)
Jul-15-25 04:05PM	MeridianLink Appoints Tech Veteran Denise Cox as Chief Customer Officer (Business Wire)
Jul-14-25 04:01PM	Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025 (Business Wire)
Jul-09-25 12:13PM	Nuvem Invests in Expanded Leadership to Strengthen the Customer Experience for Community Health Providers (Business Wire)
Jul-07-25 12:01AM	3 Reasons to Sell OMCL and 1 Stock to Buy Instead (StockStory)
Jul-03-25 04:08AM	Pharmacy Automation Market Forecast Report to 2030: A $9.48 Billion Market by 2030 with a 7.45% CAGR (GlobeNewswire)
Jun-26-25 05:58PM	Omnicell's Q1 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Jun-16-25 11:38PM	Q1 Rundown: Omnicell (NASDAQ:OMCL) Vs Other Healthcare Technology for Providers Stocks (StockStory)
Jun-13-25 08:42AM	Do Options Traders Know Something About Omnicell Stock We Don't? (Zacks)
Jun-06-25 09:02AM	Is it Apt to Retain Omnicell Stock in Your Portfolio Now? (Zacks)
Jun-05-25 11:31AM	Omnicell (OMCL) Up 27% Since Last Earnings Report: Can It Continue? (Zacks)
May-31-25 05:59AM	Down Over 30%: Wells Fargo Says Now Is the Time to Load Up on These 2 Beaten-Down Stocks (TipRanks)
May-22-25 01:25PM	Why Omnicell (OMCL) Stock Is Trading Up Today (StockStory) +5.49%
08:30AM	Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program (Business Wire)
May-19-25 08:33AM	OMCL Q1 Earnings Call: Revenue Tops Expectations but Tariff Headwinds Pressure Profit Outlook (StockStory)
May-15-25 08:55AM	Omnicell's New Perioperative Clinic Setting Products May Boost Stock (Zacks)
May-14-25 04:01PM	Omnicell Announces New Products for Perioperative and Clinic Settings (Business Wire)
08:30AM	Omnicell Opens New Innovation Lab in Austin, Texas (Business Wire)
May-07-25 01:25PM	Omnicell: Facing New Headwinds (Seeking Alpha)
09:20AM	Omnicell Q1 Earnings & Revenues Beat, '25 EPS View Down, Stock Up (Zacks)
03:07AM	Omnicell Inc (OMCL) Q1 2025 Earnings Call Highlights: Navigating Tariff Challenges and Revenue ... (GuruFocus.com)
01:35AM	Q1 2025 Omnicell Inc Earnings Call (Thomson Reuters StreetEvents)
May-06-25 07:40AM	Omnicell (OMCL) Beats Q1 Earnings and Revenue Estimates (Zacks) -15.84%
06:43AM	Omnicell: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	Omnicell Announces First Quarter 2025 Results (Business Wire)
May-02-25 10:56AM	Can Sustained Product Demand Drive HIMS Stock Before Q1 Earnings? (Zacks)
Apr-29-25 05:06AM	Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks (StockStory)
Apr-28-25 09:40AM	Why Omnicell (OMCL) is a Top Value Stock for the Long-Term (Zacks)
05:04AM	Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks (StockStory)
Apr-27-25 01:09PM	1 of Wall Street's Favorite Stock to Target This Week and 2 to Keep Off Your Radar (StockStory)
Apr-22-25 07:29AM	Is it Apt to Retain Omnicell Stock in Your Portfolio Now? (Zacks)
Apr-14-25 04:01PM	Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025 (Business Wire)
Apr-10-25 05:08PM	Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know (StockStory)
09:40AM	Here's Why Omnicell (OMCL) is a Strong Value Stock (Zacks)
Apr-08-25 05:12AM	Omnicell (OMCL): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Mar-25-25 09:40AM	Why Omnicell (OMCL) is a Top Value Stock for the Long-Term (Zacks)
Mar-24-25 04:01PM	Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer (Business Wire)
Mar-12-25 08:30AM	Omnicell Announces Chief Financial Officer Transition (Business Wire) -6.64%
Feb-28-25 08:02AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
Feb-24-25 12:00PM	Omnicell (OMCL) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Feb-11-25 09:55AM	Wall Street Analysts Think Omnicell (OMCL) Could Surge 29.03%: Read This Before Placing a Bet (Zacks)

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Randall Lipps	Officer	Dec 01 '25	Proposed Sale	35.97	28,250	1,016,092		Dec 01 01:12 PM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Nov 17 '25	Sale	34.90	3,473	121,208	104,388	Nov 18 04:13 PM
Manley Corey J	Officer	Nov 17 '25	Proposed Sale	34.90	3,473	121,208		Nov 17 10:36 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Sep 12 '25	Sale	33.25	3,880	129,010	110,653	Sep 16 04:09 PM
Manley Corey J	Officer	Sep 12 '25	Proposed Sale	33.25	3,880	129,010		Sep 12 11:36 AM
LIPPS RANDALL A	CHAIRMAN, PRESIDENT AND CEO	Mar 14 '25	Buy	33.13	10,561	349,874	333,610	Mar 18 04:13 PM
PARRISH MARK W	Director	Dec 10 '24	Sale	47.30	12,000	567,638	58,427	Dec 12 04:03 PM
PARRISH MARK W	Director	Dec 10 '24	Proposed Sale	46.00	12,000	552,000		Dec 10 04:51 PM

Cyber Swan Sale

50% Off Elite

COO

Cooper Companies, Inc

OMCL

Omnicell, Inc

Upgrade your FINVIZ experience